Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
March 21st, 2022
California Businesses Gain Clarity on Consumer Data Requests
Privacy & Data Security Practice Group Chair Daniel M. Goldberg is quoted in the article, “California Businesses Gain Clarity on Consumer Data Requests” published by Bloomberg Law. The article discusses Attorney General Rob Bonta’s opinion under the California Consumer Privacy Act that consumers have a right to access inferences, regardless of whether those are generated by a company’s data or data from another source. Daniel says, “Many companies were already treating inferences as personal information under the law and responding to consumer requests accordingly.” Adding, “[Attorney General] Bonta’s opinion should convince any holdouts that treating generated inferences differently than acquired personal information isn’t a tenable approach.”
Daniel points out an unclear piece of the opinion, “Still, the opinion doesn’t expressly address whether consumers’ right to delete and right to correct—which will go into effect when amendments to the CCPA become operative on Jan. 1, 2023—extends to inferences as well.” Daniel concludes by saying, “The bigger issue for me is: Where do we go from here?”
Read the full article here. (Behind paywall)
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
